Investors
Our progress on #FutureFresenius
- We are progressing on our journey towards #FutureFresenius with a simplified structure, sharper focus and accelerated performance
- We successfully completed the deconsolidation of Fresenius Medical Care - a landmark in the implementation of the #FutureFresenius program
- We place a clear focus on our Operating Companies Fresenius Kabi and Fresenius Helios: both have attractive market positions and excellent opportunities for profitable growth
- We are actively managing our portfolio of assets where Fresenius lacks best ownership: our divestment program is well advancing
- With our Fresenius Financial Framework, we set ambitious EBIT margin bands for our business segments
- Fresenius Vamed’s transformation is progressing well with ongoing operational improvements
- We significantly exceeded our Group cost saving target in 2023 by more than 40% and raised our 2025 structural productivity savings target
May 08, 2024 - 01:30 pm
Bad Homburg, Germany
Conference Call Q1 2024, Fresenius
Live Webcast
“We took decisive actions in fiscal year 2023 and put Fresenius back on track. #FutureFresenius is driving improvements throughout the company and creating value. We added focus, simplified the structure, and delivered better financial performance. We will build on that momentum to further grow our businesses and accelerate earnings growth driven by the Operating Companies Fresenius Kabi and Fresenius Helios.”
Michael Sen, Chairman of the Management Board
#FutureFresenius
In less than one year we successfully completed the deconsolidation of Fresenius Medical Care – a landmark of our #FutureFresenius agenda. Read more in our #FutureFresenius stories.
Non-Financial Report
Our innovations enable us to offer products and services that provide high-quality and affordable therapies to critically and chronically ill patients. Read more in our Non-Financial Report.
Letter to our shareholders
For Fresenius, 2023 was a year of change and new beginnings. We successfully launched our #FutureFresenius corporate strategy and set the course for profitable growth.
Interactive tool
With our interactive tool you can analyze and graph a variety of key figures of the Fresenius Group and the business segments on an annual and quarterly basis.